Precigen, Inc. Common Stock PGEN
Key Stats
- Today's Range
- $3.53 – $3.88
- 50-Day Range
- $3.22 – $4.87
- 52-Week Range
- $1.23 – $5.46
- Volume
- 5.33 million shs
- Average Volume
- 4.12 million shs
- Market Cap
- $1.38 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 9.35%
- Days to Cover
- 37.16
About Precigen, Inc. Common Stock
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.